Literature DB >> 23555508

Lowered LDL-C Levels Reduce Later Local Vascular Events after Surgical or Endovascular Treatment of Peripheral Artery Disease.

Kouji Ishii1, Junichiro Takahashi, Tsuyoshi Kanaoka, Yutaka Wakamatsu, Toshihiro Gohda, Shigeyuki Sasaki, Yoshiro Matsui.   

Abstract

PURPOSE: To examine the relationship between incidence of later, local vascular events (restenosis and occlusion) and clinical factors including lipid levels after surgical or endovascular treatment of peripheral artery disease (PAD).
METHODS: Consecutive 418 PAD lesions (in 308 patients under the age of 70) treated with surgical (n = 188) or endovascular (n = 230) repair for iliac (n = 228) and infrainguinal (n = 190) lesions were retrospectively analyzed. Clinical features and lipid levels were compared between patients who developed vascular events (n = 51; VE group) and those who did not (n = 257; NoVE group).
RESULTS: Among assessed factors, post-therapeutic low-density lipoprotein cholesterol (LDL-C) levels (mg/dL) were significantly higher in the VE group (120.4 ± 31.2) than in the NoVE group (108.2 ± 25.1) (P = 0.01). Infrainguinal lesions were more common in the VE than in the NoVE group (P <0.001). Cox hazard analysis indicated that infrainguinal lesions relative to iliac lesions significantly increased the risk of vascular events (hazard ratio (HR) 3.35; 95% CI 1.63-6.90; P = 0.001) and post-therapeutic LDL-C levels <130 (mg/dL) decreased the risk (HR 0.34; 95%CI 0.17-0.67; P = 0.002).
CONCLUSION: Lowered post-therapeutic LDL-C levels can decrease the risk of later, local vascular events after PAD treatment. These results may support the rationale for aggressive lipid-modifying therapy for PAD.

Entities:  

Keywords:  LDL-C; PAD; dyslipidemia; endovascular treatment; surgical treatment

Year:  2012        PMID: 23555508      PMCID: PMC3595866          DOI: 10.3400/avd.oa.12.00003

Source DB:  PubMed          Journal:  Ann Vasc Dis        ISSN: 1881-641X


  24 in total

1.  Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study.

Authors:  Joanne M Murabito; Jane C Evans; Kenneth Nieto; Martin G Larson; Daniel Levy; Peter W f Wilson
Journal:  Am Heart J       Date:  2002-06       Impact factor: 4.749

2.  AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.

Authors:  Sidney C Smith; Emelia J Benjamin; Robert O Bonow; Lynne T Braun; Mark A Creager; Barry A Franklin; Raymond J Gibbons; Scott M Grundy; Loren F Hiratzka; Daniel W Jones; Donald M Lloyd-Jones; Margo Minissian; Lori Mosca; Eric D Peterson; Ralph L Sacco; John Spertus; James H Stein; Kathryn A Taubert
Journal:  Circulation       Date:  2011-11-03       Impact factor: 29.690

3.  Prosthetic above-knee femoropopliteal bypass grafting: five-year results of a randomized trial.

Authors:  R M Green; W M Abbott; T Matsumoto; J R Wheeler; N Miller; F J Veith; S Money; H E Garrett
Journal:  J Vasc Surg       Date:  2000-03       Impact factor: 4.268

4.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

5.  Mortality over a period of 10 years in patients with peripheral arterial disease.

Authors:  M H Criqui; R D Langer; A Fronek; H S Feigelson; M R Klauber; T J McCann; D Browner
Journal:  N Engl J Med       Date:  1992-02-06       Impact factor: 91.245

6.  Long-term outcomes and predictors of iliac angioplasty with selective stenting.

Authors:  Toshifumi Kudo; Fiona A Chandra; Samuel S Ahn
Journal:  J Vasc Surg       Date:  2005-09       Impact factor: 4.268

7.  Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia.

Authors:  Andres Schanzer; Nathanael Hevelone; Christopher D Owens; Joshua A Beckman; Michael Belkin; Michael S Conte
Journal:  J Vasc Surg       Date:  2008-04       Impact factor: 4.268

8.  Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000.

Authors:  Elizabeth Selvin; Thomas P Erlinger
Journal:  Circulation       Date:  2004-07-19       Impact factor: 29.690

9.  Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia.

Authors:  Masunori Matsuzaki; Toru Kita; Hiroshi Mabuchi; Yuji Matsuzawa; Noriaki Nakaya; Shinichi Oikawa; Yasushi Saito; Jun Sasaki; Kazuaki Shimamoto; Hiroshige Itakura
Journal:  Circ J       Date:  2002-12       Impact factor: 2.993

10.  2011 ACCF/AHA Focused Update of the Guideline for the Management of patients with peripheral artery disease (Updating the 2005 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

Authors: 
Journal:  Circulation       Date:  2011-09-29       Impact factor: 29.690

View more
  1 in total

1.  Neutrophil-to-Lymphocyte Ratio Predicts Restenosis After Drug-Coated Balloon Therapy for Femoropopliteal Artery Lesions: A Retrospective Study.

Authors:  Zhihong Wang; Lei Sheng; Hongbin Gu; Fan Yang; Huajie Xie; Mingfei Li
Journal:  Front Cardiovasc Med       Date:  2022-07-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.